Improving Lives, Globally™

Led by a world-class team of scientist-entrepreneurs,
Anji is a biotech company focused on medicines that bring meaningful benefits to patients across the globe.

Contact Us

This Is Where Science Gets Done

Anji is agnostic to technology and modality. We care most about pursuing drug targets with the greatest potential to improve lives, as efficiently as possible.

ANJ900

Gut-targeted Type 2 diabetes therapy for patients with chronic kidney disease.

Learn More

ANJ908

A novel mechanism to treat chronic constipation.

Learn More
See Full Pipeline

Building Bridges to
Life-Changing Medicines

Our name was inspired by the Anji Bridge (Zhaozhou Bridge), one of the oldest stone-arch bridges in the world. Anji translates to “safe crossing” and “to aid those in need.” Our biotech company bridges science and culture to deliver safe and effective medicines to patients who need them most.

About Anji

Our Team

Anji was built with a fervent desire to improve lives. Our pedigreed team blends deep drug development know-how with an unwavering resolve to get things done. Rather than focusing on what’s trendy, we focus on what works.

Meet the Team

What’s Happening at Anji

Anji to Advance MCL1 Inhibitor Program from Broad Institute into Clinical Trials

Read More

Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 Diabetes Patients with Kidney Disease

Read More

Anji Pharma Adds Clinical Sites to Accelerate Clinical Development of Pradigastat for the Treatment of Functional Constipation

Read More

For Patients

We’ve provided additional information and resources to untangle the diseases we aim to treat.

Resources

For partnerships, investment opportunities, or
to learn more about our work, contact us.

Contact Us